Markston International’s Humana HUM Stock Holding History

Markston International’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-900	Closed	-$184K	–	198
2016 Q4	$184K	Hold	900	–	–	0.02%	130
2016 Q3	$159K	Buy	+900	New	+$156K	0.01%	131

Other funds holding HUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Markston International's HUM Position: Q1 2017 in Review

Markston International sold out of Humana (HUM) in Q1 2017, closing a stake of 900 shares — an estimated $184K sold.

Markston International first reported a position in HUM in Q3 2016 and held it in 2 quarters. The position peaked at $184K in Q4 2016. 613 funds tracked by Wall St. Rank hold HUM as of Q1 2017.

Markston International reported no remaining Humana position as of Q1 2017 after selling out during the quarter.
Markston International sold 900 Humana shares in Q1 2017, an estimated $184K.
Markston International first reported a position in Humana in Q3 2016 and held it in 2 quarters.
Markston International's Humana position peaked at $184K in Q4 2016.
613 funds tracked by Wall St. Rank held Humana as of Q1 2017.

Based on Markston International's 13F filing for Q1 2017, filed 2 May 2017.